FDA is warning prescribers about dental problems connected to buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain. Some dental problems reported in patients include: 

  • Tooth decay, 
  • Development of cavities, 
  • Infections, and 
  • Erosion in teeth. 

FDA noted they are taking several measures to protect the public health, including requiring that a new warning about the risk of dental problems be added to the prescribing information and the patient Medication Guide for all buprenorphine-containing medicines that are dissolved in the mouth.